tiprankstipranks
Advertisement
Advertisement
Repligen assumed with an Outperform at Wolfe Research
PremiumThe FlyRepligen assumed with an Outperform at Wolfe Research
1M ago
Repligen Shareholders Approve Directors, Auditor and Pay Plan
Premium
Company Announcements
Repligen Shareholders Approve Directors, Auditor and Pay Plan
2M ago
Repligen resumed with an Outperform at RBC Capital
Premium
The Fly
Repligen resumed with an Outperform at RBC Capital
2M ago
Repligen raises FY26 EPS view to $1.97-$2.05 from $1.93-$2.10, consensus $1.97
PremiumThe FlyRepligen raises FY26 EPS view to $1.97-$2.05 from $1.93-$2.10, consensus $1.97
2M ago
Repligen reports Q1 adjusted EPS 48c, consensus 38c
Premium
The Fly
Repligen reports Q1 adjusted EPS 48c, consensus 38c
2M ago
RGEN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RGEN Upcoming Earnings Report: What to Expect?
2M ago
Repligen price target lowered to $145 from $175 at Barclays
PremiumThe FlyRepligen price target lowered to $145 from $175 at Barclays
3M ago
Repligen price target lowered to $140 from $170 at Evercore ISI
Premium
The Fly
Repligen price target lowered to $140 from $170 at Evercore ISI
3M ago
Repligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating
Premium
Ratings
Repligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100